Suzanne Elvidge

Suzanne Elvidge

I'm a freelance writer

More than 20 years of experience in communicating biotechnology, pharmaceuticals, and business

  • 380
    stories
  • 170K
    words
380
stories for
16
publications
Suzanne Elvidge's stories for
Show all
validinsight.com

Funding challenges of super-high-cost therapeutics

Funding super-high-cost medicines is proving challenging, at least partly because of the level of uncertainty for long-term, real-world benefits

validinsight.com

Real-world data: Social media beyond pharmacovigilance

Social media, from Facebook to Twitter, and LinkedIn to Pinterest, is creating real-world data at an unprecedented rate

validinsight.com

Drug launch excellence: Begin the value story early

Getting a drug to market is a long and challenging process; the journey from the lab bench to the patient’s bedside can take around 12 years

pharmaceuticalonline.com

The Challenges Of Bringing A Cannabis-Based Drug To Market

Bringing a drug to market is always tough, but is getting approval for a cannabis extract any harder? It doesn’t seem that way for GW Pharmaceuticals.

New Scientist

US pharma industry is fighting fit - New Scientist

No longer in a downward spiral, the pharmaceutical industry is going from strength to strength. New Scientist uncovers the career opportunities...

medtechengine.com

What’s new in clinical practice? How clinical trials and regulatory processes in medtech are changing

Medtech has traditionally required fewer clinical trials than pharmaceuticals, but changes are on the horizon for the regulatory processes in the European Union, which may mean more of a focus on studies in patients. Suzanne Elvidge investigates the makeover

pharmaceutical-journal.com

Antidiabetic agent could smother pancreatic cancer stem cells ...

Antidiabetic agent could smother pancreatic cancer ...

Nature

Early-access scheme picks controversial glioblastoma vaccine ...

A US-made cancer vaccine has become the first product to enter the UK's early-access pathway, a new scheme to fast-track patient access to investigational drugs for diseases with no adequate treatment.

1069161 ear close up hearing loss 15 article
pharmaceutical-journal.com

Inflammation increases risk of hearing loss with antibiotic treatment ...

Inflammation increases risk of hearing loss with an...

pharmaceutical-journal.com

Melatonin levels may explain seasonal variation in MS relapses ...

Melatonin levels may explain seasonal variation in ...

pharmaceutical-journal.com

PCSK9 inhibitors herald new era of cholesterol lowering | Editorial ...

PCSK9 inhibitors herald new era of cholesterol lowe...

rainbowseedfund.com

The Rainbow Seed Fund: funding for promising technology companies

The Rainbow Seed Fund: funding for promising techno...

pharmaceutical-journal.com

Dexamethasone improves septic arthritis in children | Research ...

Dexamethasone improves septic arthritis in children...

pharmaceutical-journal.com

Proton pump inhibitors linked with low risk of lupus, says UK regulator

Proton pump inhibitors linked with low risk of lupu...

pharmaceutical-journal.com

Actinic keratosis gel linked with allergic reactions and shingles ...

Actinic keratosis gel linked with allergic reaction...